Cargando…

Impact of sustained virologic response on chronic kidney disease progression in hepatitis C

AIM: To determine how sustained virological response at 12 wk (SVR12) with direct acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection affects chronic kidney disease (CKD) progression. METHODS: A retrospective analysis was performed in patients aged ≥ 18 years treated for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aby, Elizabeth S, Dong, Tien S, Kawamoto, Jenna, Pisegna, Joseph R, Benhammou, Jihane N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756725/ https://www.ncbi.nlm.nih.gov/pubmed/29359019 http://dx.doi.org/10.4254/wjh.v9.i36.1352

Ejemplares similares

Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
por: Dong, Tien S, et al.
Publicado: (2018)

Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study
por: Colussi, GianLuca, et al.
Publicado: (2019)

Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue
por: Ramji, Alnoor, et al.
Publicado: (2022)

Race affects SVR12 in a large and ethnically diverse hepatitis C‐infected patient population following treatment with direct‐acting antivirals: Analysis of a single‐center Department of Veterans Affairs cohort
por: Benhammou, Jihane N., et al.
Publicado: (2018)

Durability of Sustained Virologic Response in Chronic Hepatitis C
por: Uyanikoglu, Ahmet, et al.
Publicado: (2013)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
por: Abadía, Marta, et al.
Publicado: (2019)

Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
por: Kaneko, Rena, et al.
Publicado: (2018)

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

A Telephone and Mail Outreach Program Successfully Increases Uptake of Hepatocellular Carcinoma Surveillance
por: Aby, Elizabeth S., et al.
Publicado: (2020)

Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals
por: Chen, Yi-Chun, et al.
Publicado: (2019)

Histopathology and the predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy
por: Huang, Rui, et al.
Publicado: (2021)

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody
por: Maylin, Sarah, et al.
Publicado: (2009)

Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey
por: Tan, You-Wen, et al.
Publicado: (2018)

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017)

Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017)

Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
por: Noureddin, Mazen, et al.
Publicado: (2018)

Perinatal transmission in infants of mothers with chronic hepatitis B in California
por: Burgis, Jennifer C, et al.
Publicado: (2017)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
por: Tseng, Chih-Wei, et al.
Publicado: (2016)

Evaluation of and implications for a novel hepatitis C e-consult direct-to-treatment pilot program
por: Mohtashemi, Neaka Z., et al.
Publicado: (2023)

Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China
por: Pan, Calvin Q, et al.
Publicado: (2022)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease
por: Vidot, Helen, et al.
Publicado: (2017)

Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States
por: Yuan, Qing, et al.
Publicado: (2023)

Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral
por: Li, Xiao-He, et al.
Publicado: (2022)

Retrospective study of the associations between hepatitis C virus infection and metabolic factors
por: Yair-Sabag, Shira, et al.
Publicado: (2016)

Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort
por: Steinebrunner, Niels, et al.
Publicado: (2018)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study
por: Chen, Yu-Jung, et al.
Publicado: (2017)

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
por: Mezina, Anya, et al.
Publicado: (2022)

Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil
por: Vaucher, Manoela Badinelli, et al.
Publicado: (2023)

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety
por: Latt, Nyan L, et al.
Publicado: (2017)

Retrospective analysis of hepatitis C infected patients treated through an integrated care model
por: Levin, James M, et al.
Publicado: (2016)

Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
por: Chindamo, Maria Chiara, et al.
Publicado: (2017)

Serum vitamin D and vitamin-D-binding protein levels in children with chronic hepatitis B
por: Huang, Cai-Zhi, et al.
Publicado: (2021)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
por: Welsch, Christoph, et al.
Publicado: (2017)

Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
por: Low, En Xian Sarah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sigev6orcofiqclbrfgdm4akq7